Natural Capsules Ltd.
Snapshot View

527.90 0.00

08 December 2022, 04:01:00 PM
Volume: 2,271

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.naturalcapsules.com
Market Cap 489.52 Cr.
Enterprise Value(EV) 561.76 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 21.14 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 24.98 Trailing Twelve Months Ending 2022-09
Industry PE 34.64 Trailing Twelve Months Ending 2022-09
Book Value / Share 109.84 Trailing Twelve Months Ending 2022-09
Price to Book Value 4.81 Calculated using Price: 527.90
Dividend Yield 0.19 Period Ending 2022-03
No. of Shares Subscribed 0.93 Cr. 9,349,050 Shares
FaceValue 10
Company Profile
Natural Capsules is a public limited company established in the year 1993.The company is a well-equipped modern manufacturing plant to manufacture hard gelatin capsule shells, Hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-1.54%
1 Month
-6.12%
3 Month
-17.70%
6 Month
+19.25%
1 Year
+123.88%
2 Year
+678.96%
5 Year
+687.56%
10 Year
+1527.81%
5 years 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.05 3.50 1.54 11.74 19.18
Return on Capital Employed (%) 3.71 4.51 3.71 14.52 20.92
Return on Assets (%) 1.56 2.66 1.16 8.05 10.65

Balance Sheet View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 54 55 56 62 83 101
Non Curr. Liab. 2 1 1 2 35 58
Curr. Liab. 15 16 18 33 46 63
Minority Int.
Equity & Liab. 71 73 75 97 164 223
Non Curr. Assets 29 35 37 47 89 121
Curr. Assets 42 38 38 50 76 102
Misc. Exp. not W/O
Total Assets 71 73 75 97 164 223

Profit Loss View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 55 60 62 80 135 168
Other Income 1 1 1 1 2 1
Total Income 56 61 63 80 137 170
Total Expenditure -49 -55 -56 -68 -111 -134
PBIDT 6 6 6 12 27 36
Interest 0 -1 -1 -1 -2 -3
Depreciation -4 -3 -4 -4 -5 -6
Taxation -1 0 -1 -2 -5 -7
Exceptional Items 0 2
PAT 1 2 1 7 14 20
Minority Interest
Share Associate
Other Related Items 0 0
Consolidated Net Profit 1 2 1 7 14 20
Adjusted EPS 1 3 1 9 20 27

Cash Flow View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 5 2 7 6 1
Cash Fr. Inv. -1 -7 -6 -9 -46
Cash Fr. Finan. -4 4 -1 3 46
Net Change 0 -1 0 0 1
Cash & Cash Eqvt 1 0 0 0 1

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 52.17 54.37 54.37 54.37 54.38 56.58 56.57 56.57 56.56
Public 47.83 45.63 45.63 45.63 45.62 43.42 43.43 43.43 43.44
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 22 Nov 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing obligations & Disclosure Requirements) Regulations 2015 we wish to bring to inform that a shareholder has reported to company about loss of his share certificate and requested the Company to issue a duplicate share certificate. The particulars relating to loss of share certificate are attached.
Mon, 21 Nov 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing obligations & Disclosure Requirements) Regulations 2015 we wish to bring to inform that two shareholders have reported to company about loss of their share certificate and requested the Company to issue a duplicate share certificate. The particulars relating to loss of share certificate are attached.
Sat, 19 Nov 2022
Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
We wish to inform you that below investors have invested ? 18.75 Crore in our Subsidiary Company M/S Natural Biogenex Private Limited for 7.69% of the total outstanding shares post-allotment valuing the subsidiary at ? 225 Crores pre-money.1. Mr. Dinesh Kumar Singhi - an investment of ? 12.51 Crore;2. Mr. Laxmipat Dudheria - an investment of ? 6.24 Crore.The Board of M/S Natural Biogenex Private Limited (Wholly owned Subsidiary) on their meeting held today i.e. 19.11.2022 have considered and approved below:1. Allotment of 11 12 000 equity shares representing 5.13% of total outstanding shares post-allotment of ? 10/- each at a premium of ? 102.50 totaling to ? 112.50 per shares to Mr. Dinesh Kumar Singhi;2. Allotment of 5 55 000 equity shares representing 2.56% of total outstanding shares post-allotment of ? 10/- each at a premium of ? 102.50 totaling to ? 112.50 per shares to Mr. Laxmipat Dudheria.

Technical Scans View Details >>

Thu, 08 Dec 2022
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Decrease 1 Month High Decrease 1 Month
High Decrease 3 Months High Decrease 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,362.76 980.95 -3.6%
Cipla Ltd. 89,585.15 1,110.00 +0.4%
Divi's Laboratories Ltd. 87,333.85 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. 72,223.59 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. 67,735.51 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. 54,831.55 1,620.10 -0.4%
Abbott India Ltd. 43,044.71 20,257.00 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 57.34 980.95 -3.6%
Cipla Ltd. Consolidated 2022-09 34.91 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 29.18 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.23 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.68 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.80 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-09 48.82 20,257.00 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.43 980.95 -3.6%
Cipla Ltd. Consolidated 2022-09 4.09 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 7.20 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.48 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.32 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.00 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-09 15.86 20,257.00 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 0.00 20,257.00 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,257.00 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,257.00 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,257.00 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 798.70 20,257.00 +0.2%

FAQ's On Natural Capsules Ltd.

What is Natural Capsules share price?

Can I buy Natural Capsules shares now?

What is the Dividend Yield of Natural Capsules?

What is the Market Cap of Natural Capsules?

What are the key metrics to analyse Natural Capsules?

What is the 52 Week High and Low of Natural Capsules?

What is the trend of Natural Capsules share price?